Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07319728

Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis

A single blind randomized controlled clinical study

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Minia University

Minya, Minya Governorate, 11666, Egypt

About this study

A single blind randomized controlled clinical study

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient diagnosed with osteoarthritis in knee by:

Full history taking Physical examination including (joint tenderness, swelling, crepitus and limitation of motion).

Exclusion criteria

  • 1. Patients with dual diagnosis 2. Patients have skin lesion or dermatologic disease in the treatment area

Treatment and study plan

Ketoprofen

Drug

new gel formulation

Primary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: 2 weeks

  2. McMaster Universities Arthritis Index (WOMAC)

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

New Valley University

Other

Registry information

Official study title

Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis: Comprehensive In-Vitro and Clinical Assessment

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 6, 2026
Registry last updated
Jan 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.